← Eichor
Condition: Immunosuppressive Treatment Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immunosuppressive Treatment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454Optimizing Treatment on Idiopathic Inflammatory Myopathies
Phase N/A · 1 location(s) · University of Sao Paulo · NCT03092180Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Phase 3 · 1 location(s) · Air Force Military Medical University, China · NCT05510323Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Live
Phase 4 · 18 location(s) · University Hospital, Limoges · NCT06354179A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite I
Phase 2 · 96 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07015983Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arr
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06591260Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT03279094The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofet
Phase 1/Phase 2 · 2 location(s) · National Cancer Institute (NCI) · NCT05436418AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis
Phase 1 · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT05832515Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic an
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT04521790Relationship Between Immunosuppressive Treatment Status and Clinical Course of Parkinson's Disease
Phase N/A · 1 location(s) · Medical University of Warsaw · NCT06834191The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
NA · 1 location(s) · Nationwide Children's Hospital · NCT07718204Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
NA · 1 location(s) · University of Sao Paulo · NCT03399175Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07516288Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06695741Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children
Phase 1/Phase 2 · 1 location(s) · Rafael Correa-Rocha · NCT04924491Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
Phase 2 · 1 location(s) · Haukeland University Hospital · NCT04936854Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial
NA · 1 location(s) · Hospital de Granollers · NCT07486206Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Phase 1/Phase 2 · 34 location(s) · Lyell Immunopharma, Inc. · NCT05826535Combined Immunosuppression for Pediatric Crohn's Disease
Phase 4 · 1 location(s) · Children's Hospital of Fudan University · NCT05043870Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06613880TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
Phase N/A · 1 location(s) · Tang-Du Hospital · NCT04182984Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT
NA · 1 location(s) · Xijing Hospital · NCT06900777Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Phase 2 · 5 location(s) · Gulam Manji · NCT06048484Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at R
Phase 2 · 4 location(s) · Nantes University Hospital · NCT04180085Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severel
Phase 3 · 85 location(s) · AbbVie · NCT06332534Different Immunosuppressive Treatment in iMN
Phase 3 · 1 location(s) · Peking Union Medical College Hospital · NCT04745728Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
Phase N/A · 1 location(s) · Western Galilee Hospital-Nahariya · NCT06821919Abatacept for the Treatment of Giant Cell Arteritis
Phase 3 · 9 location(s) · University of Pennsylvania · NCT04474847Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy
Phase 2 · 4 location(s) · University Hospital, Montpellier · NCT07493395
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.